Xenitra (ASX:XEN) announced an escalation of its presence in the Chinese market through a dual-agreement strategic partnership with the multi-billion dollar Rockcheck Group.
The announcement includes a formalised supply agreement for Danone products, targeting sales of 140 million Chinese yuan over a twelve-month period commencing May 1.
The deal builds upon a successful existing relationship, with Xenitra having already recorded over $10 million in sales to Rockcheck during the current financial year.
Under the new terms, both parties retain an option to extend the partnership for an additional three years, contingent on performance during the initial quarter.
Beyond the immediate revenue boost from Danone products, the second, broader "supply framework agreement" designates Xenitra's Australian trading subsidiary as an authorised supplier to the Rockcheck conglomerate.
This establishes a critical B2B sales channel that allows brand partners within the Xenitra ecosystem to have their products procured directly in Australia for distribution into Rockcheck’s extensive Chinese network.
The move marks a pivotal moment for the Sydney-based FMCG and nutraceuticals specialist following a period of corporate rebranding and board restructuring.
By leveraging its established e-commerce infrastructure alongside this new B2B gateway, Xenitra aims to accelerate its trajectory toward profitability.
At the time of reporting, Xenitra's share price was $0.0040.